Home Featured Page 61

Featured

Latest

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

The High Guide – Unlocking the Potential: Psychedelic Workforce Insights with...

Industry and Researchers Respond to ICER Report on MDMA-Assisted Therapy, Which...

RIPPLES of Hope: Psychedelics as a Tool for Peacebuilding and Collective...

Unlocking Creativity: How Psychedelics Are Influencing Modern Design

Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family...

Australian Federal Government Funds Trial of MDMA-Assisted Therapy for Individuals Affected...

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in...

The Church of the Eagle and the Condor Settles with Federal...

Early Research, Psychedelics in Palliative Care, and the Intersection of Science...

EDITOR PICKS

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

The High Guide – Unlocking the Potential: Psychedelic Workforce Insights with...

Industry and Researchers Respond to ICER Report on MDMA-Assisted Therapy, Which...

RIPPLES of Hope: Psychedelics as a Tool for Peacebuilding and Collective...

Unlocking Creativity: How Psychedelics Are Influencing Modern Design

Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals

The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family...

Australian Federal Government Funds Trial of MDMA-Assisted Therapy for Individuals Affected...

European Medicines Agency CMO Talks Psychedelics and Their Therapeutic Use in...

The Church of the Eagle and the Condor Settles with Federal...

Early Research, Psychedelics in Palliative Care, and the Intersection of Science...

EDITOR PICKS

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY